Skip to main content
Top
Published in: Head and Neck Pathology 1/2020

01-03-2020 | Case Report

Acantholytic Squamous Cell Carcinoma and Salivary Duct Carcinoma Ex-pleomorphic Adenoma of the Submandibular Gland: A Report of Two Extremely Rare Cases with an Immunohistochemical Analysis

Authors: Kimihide Kusafuka, Takuya Kawasaki, Tetsuro Onitsuka, Noriko Hamaguchi, Kotaro Morita, Takashi Mukaigawa, Yukio Nishiya, Tomoyuki Kamijo, Yoshiyuki Iida, Takashi Nakajima, Takashi Sugino

Published in: Head and Neck Pathology | Issue 1/2020

Login to get access

Abstract

Carcinoma ex pleomorphic adenoma (CXPA) is a malignant tumor of the salivary gland that arises from pleomorphic adenoma (PA). Squamous cell carcinoma (SCC) is extremely rare in the salivary glands. We report two cases of acantholytic SCC (ASCC) ex PA. Case 1 involved a 72-year-old female, and case 2 involved a 67-year-old male. Histologically, both cases involved PA, and salivary duct carcinoma (SDC) components, which were positive for androgen receptor (AR) and gross cystic disease fluid protein (GCDFP)-15 but negative for HER2, were seen in the intracapsular regions. The invasive components consisted of ASCC, which were positive for cytokeratin 5/6 and p63 but negative for AR and GCDFP-15. The SDC and ASCC components were positive for the epidermal growth factor receptor. In both cases, the cytoplasmic localization or decreased expression of E-cadherin was observed in the ASCC. In the early phase, CXPA might emerge as SDC, and it might change into SCC as it invades beyond the capsule due to changes in microenvironment. Also, the aberrant expression of E-cadherin is related to acantholysis in SCC.
Literature
1.
go back to reference Gnepp DR. Malignant mixed tumours of the salivary glands: a review. Pathol Annu. 1993;28:279–328.PubMed Gnepp DR. Malignant mixed tumours of the salivary glands: a review. Pathol Annu. 1993;28:279–328.PubMed
2.
go back to reference Nagao T, Licitra L, Loening T, et al. Salivary duct carcinoma. In: El-Nagger AK, Chan JKC, Grandis JR et al, editors. WHO classification of head and neck tumours. Lyon: IARC; 2017. pp. 173–5. Nagao T, Licitra L, Loening T, et al. Salivary duct carcinoma. In: El-Nagger AK, Chan JKC, Grandis JR et al, editors. WHO classification of head and neck tumours. Lyon: IARC; 2017. pp. 173–5.
3.
go back to reference Lim CM, Hobson C, Kim S, et al. Clinical outcome of patients with carcinoma ex pleomorphic adenoma of the parotid gland: a comparative study from a single tertiary center. Head Neck. 2015;37:543–7.CrossRef Lim CM, Hobson C, Kim S, et al. Clinical outcome of patients with carcinoma ex pleomorphic adenoma of the parotid gland: a comparative study from a single tertiary center. Head Neck. 2015;37:543–7.CrossRef
4.
go back to reference Udager AM, Chiosea SI. Salivary duct carcinoma: an update on morphologic mimics and diagnostic use of androgen receptor immunohistochemistry. Head Neck Pathol. 2017;11:288–94.CrossRef Udager AM, Chiosea SI. Salivary duct carcinoma: an update on morphologic mimics and diagnostic use of androgen receptor immunohistochemistry. Head Neck Pathol. 2017;11:288–94.CrossRef
5.
go back to reference Rosa JC, Fonseca I, Felix A, et al. Immunohistochemical study of c-cerbB-2 expression in carcinoma ex-pleomorphic adenoma. Histopathology. 1996;28:247–52.CrossRef Rosa JC, Fonseca I, Felix A, et al. Immunohistochemical study of c-cerbB-2 expression in carcinoma ex-pleomorphic adenoma. Histopathology. 1996;28:247–52.CrossRef
6.
go back to reference Taxy JB. Squamous cell carcinoma in a major salivary gland: a review of the diagnostic considerations. Arch Pathol Lab Med. 2001;125:740–5.PubMed Taxy JB. Squamous cell carcinoma in a major salivary gland: a review of the diagnostic considerations. Arch Pathol Lab Med. 2001;125:740–5.PubMed
7.
go back to reference Weedon D. Strutton G, Rubin A. Adenoid squamous cell carcinoma. Weedon’s skin pathology, 3th edn. London: Churchill Livingstone; Elsevier; 2010. p. 694–695. Weedon D. Strutton G, Rubin A. Adenoid squamous cell carcinoma. Weedon’s skin pathology, 3th edn. London: Churchill Livingstone; Elsevier; 2010. p. 694–695.
8.
go back to reference Cassarino DS, Derienzo DP, Barr RJ. Cutaneous squamous cell carcinoma (adenoacanthoma): a comprehensive clinicopathologic classification. Part one. J Cutan Pathol. 2006; 33: 191–206.PubMed Cassarino DS, Derienzo DP, Barr RJ. Cutaneous squamous cell carcinoma (adenoacanthoma): a comprehensive clinicopathologic classification. Part one. J Cutan Pathol. 2006; 33: 191–206.PubMed
9.
go back to reference Garcia C, Crowson AN. A catholytic squamous cell carcinoma: is it really a more-aggressive tumor? Dermatol Surg. 2011;37:353–6.CrossRef Garcia C, Crowson AN. A catholytic squamous cell carcinoma: is it really a more-aggressive tumor? Dermatol Surg. 2011;37:353–6.CrossRef
10.
go back to reference Lewis JE, Olsen KD, Sebo TJ. Carcinoma ex pleomorphic adenoma: pathologic analysis of 73 cases. Hum Pathol. 2001;32:596–604.CrossRef Lewis JE, Olsen KD, Sebo TJ. Carcinoma ex pleomorphic adenoma: pathologic analysis of 73 cases. Hum Pathol. 2001;32:596–604.CrossRef
11.
go back to reference Nakamori K. Ohuchi T, Hasegawa T, et al. Carcinoma ex pleomorphic adenoma of the buccal region is composed of salivary duct carcinoma and squamous cell carcinoma components. Int J Oral Maxillofac Surg. 2009;38:1116–8.CrossRef Nakamori K. Ohuchi T, Hasegawa T, et al. Carcinoma ex pleomorphic adenoma of the buccal region is composed of salivary duct carcinoma and squamous cell carcinoma components. Int J Oral Maxillofac Surg. 2009;38:1116–8.CrossRef
12.
go back to reference Iino M, Yamada H, Ishikawa H, et al. Carcinoma ex pleomorphic adenoma of the submandibular gland: report of a case with an unusual malignant component of clear cell squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2008;106:e30–4.CrossRef Iino M, Yamada H, Ishikawa H, et al. Carcinoma ex pleomorphic adenoma of the submandibular gland: report of a case with an unusual malignant component of clear cell squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2008;106:e30–4.CrossRef
13.
go back to reference Garth RJ. Squamous liver metastases from a carcinoma arising within a pleomorphic adenoma of the parotid gland. J Laryngol Otol. 1990;104:152–3.CrossRef Garth RJ. Squamous liver metastases from a carcinoma arising within a pleomorphic adenoma of the parotid gland. J Laryngol Otol. 1990;104:152–3.CrossRef
14.
go back to reference Magaki SD, Bhuta S, Abemayer E, et al. Carcinoma ex-pleomorphic adenoma of the parotid gland consisting of high-grade salivary duct carcinoma and keratinizing squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol. 2015;120:e169–73.CrossRef Magaki SD, Bhuta S, Abemayer E, et al. Carcinoma ex-pleomorphic adenoma of the parotid gland consisting of high-grade salivary duct carcinoma and keratinizing squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol. 2015;120:e169–73.CrossRef
15.
go back to reference Enokida T, Fujii S, Kuno H, et al. Combined salivary duct carcinoma and squamous cell carcinoma suspected of carcinoma ex pleomorphic adenoma. Pathol Int. 2016;66:460–5.CrossRef Enokida T, Fujii S, Kuno H, et al. Combined salivary duct carcinoma and squamous cell carcinoma suspected of carcinoma ex pleomorphic adenoma. Pathol Int. 2016;66:460–5.CrossRef
16.
go back to reference Skalova A, Starek I, Vanecek T, et al. Expression of HER-2/neu gene and protein in salivary duct carcinomas of parotid gland as revealed by fluorescence in situ hybridization and immunohistochemistry. Histopathology. 2003;42:348–56.CrossRef Skalova A, Starek I, Vanecek T, et al. Expression of HER-2/neu gene and protein in salivary duct carcinomas of parotid gland as revealed by fluorescence in situ hybridization and immunohistochemistry. Histopathology. 2003;42:348–56.CrossRef
17.
go back to reference Takase S, Kano S, Taka Y, et al. Biomarker immunoprofile in salivary duct carcinomas; clinicopathological and prognostic implications with evaluation of the revised classification. Oncotarget. 2017;8:59023–35.CrossRef Takase S, Kano S, Taka Y, et al. Biomarker immunoprofile in salivary duct carcinomas; clinicopathological and prognostic implications with evaluation of the revised classification. Oncotarget. 2017;8:59023–35.CrossRef
18.
go back to reference Kusafuka K, Ebihara M, Ishiki H, et al. Primary adenoid squamous cell carcinoma of the oral cavity. Pathol Int. 2006;56:78–83.CrossRef Kusafuka K, Ebihara M, Ishiki H, et al. Primary adenoid squamous cell carcinoma of the oral cavity. Pathol Int. 2006;56:78–83.CrossRef
19.
go back to reference Kusafuka K, Onitsuka T, Miki T, et al. Squamous cell carcinoma with rhabdoid features of the gingiva: a case report with unusual histology. Med Mol Morphol. 2014;47:240–5.CrossRef Kusafuka K, Onitsuka T, Miki T, et al. Squamous cell carcinoma with rhabdoid features of the gingiva: a case report with unusual histology. Med Mol Morphol. 2014;47:240–5.CrossRef
20.
go back to reference Griffin JR, Wriston CC, Peters MS, et al. Decreased expression of intercellular adhesion molecules in acantholytic squamous cell carcinoma compared with invasive well-differentiated squamous cell carcinoma of the skin. Am J Clin Pathol. 2013;139:442–7.CrossRef Griffin JR, Wriston CC, Peters MS, et al. Decreased expression of intercellular adhesion molecules in acantholytic squamous cell carcinoma compared with invasive well-differentiated squamous cell carcinoma of the skin. Am J Clin Pathol. 2013;139:442–7.CrossRef
21.
go back to reference Bayer-Garner IB, Smoller BR. The expression of syndecan-1 is preferentially reduced compared with that of E-cadherin in acantholytic squamous cell carcinoma. J Cutan Pathol. 2001;28:83–9.CrossRef Bayer-Garner IB, Smoller BR. The expression of syndecan-1 is preferentially reduced compared with that of E-cadherin in acantholytic squamous cell carcinoma. J Cutan Pathol. 2001;28:83–9.CrossRef
22.
go back to reference Lakhani SR, Rakha E, Simpson PT. Invasive lobular carcinoma. Lakhani SR, Ellis IO, Schnitt SJ, Tan PH, van de Vijver M, editors. World Health Organization Classification of Tumours of the Breast. Lyon: IARC; 2012. 40–42. Lakhani SR, Rakha E, Simpson PT. Invasive lobular carcinoma. Lakhani SR, Ellis IO, Schnitt SJ, Tan PH, van de Vijver M, editors. World Health Organization Classification of Tumours of the Breast. Lyon: IARC; 2012. 40–42.
23.
go back to reference Kusafuka K, Kawasaki T, Maeda M, et al. Salivary duct carcinoma with rhabdoid features: a salivary counterpart of pleomorphic lobular carcinoma of the breast. Histopathology. 2017;70:164–73.CrossRef Kusafuka K, Kawasaki T, Maeda M, et al. Salivary duct carcinoma with rhabdoid features: a salivary counterpart of pleomorphic lobular carcinoma of the breast. Histopathology. 2017;70:164–73.CrossRef
24.
go back to reference Gu X, Jiang R, Fowler MR. Acantholytic squamous cell carcinoma in upper aerodigestive tract: Histopathology, Immunohistochemical profile and epithelial mesenchymal transition phenotype change. Head Neck Pathol. 2012;6:438–44.CrossRef Gu X, Jiang R, Fowler MR. Acantholytic squamous cell carcinoma in upper aerodigestive tract: Histopathology, Immunohistochemical profile and epithelial mesenchymal transition phenotype change. Head Neck Pathol. 2012;6:438–44.CrossRef
Metadata
Title
Acantholytic Squamous Cell Carcinoma and Salivary Duct Carcinoma Ex-pleomorphic Adenoma of the Submandibular Gland: A Report of Two Extremely Rare Cases with an Immunohistochemical Analysis
Authors
Kimihide Kusafuka
Takuya Kawasaki
Tetsuro Onitsuka
Noriko Hamaguchi
Kotaro Morita
Takashi Mukaigawa
Yukio Nishiya
Tomoyuki Kamijo
Yoshiyuki Iida
Takashi Nakajima
Takashi Sugino
Publication date
01-03-2020
Publisher
Springer US
Published in
Head and Neck Pathology / Issue 1/2020
Electronic ISSN: 1936-0568
DOI
https://doi.org/10.1007/s12105-018-0987-2

Other articles of this Issue 1/2020

Head and Neck Pathology 1/2020 Go to the issue

Sine qua non Radiology-Pathology

Lipoma of the Parotid Gland